JOHNSON & JOHNSON (1JNJ.MI) Fundamental Analysis & Valuation

BIT:1JNJ • US4781601046

Current stock price

194.14 EUR
-7.56 (-3.75%)
Last:

This 1JNJ.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. 1JNJ.MI Profitability Analysis

1.1 Basic Checks

  • In the past year 1JNJ was profitable.
  • 1JNJ had a positive operating cash flow in the past year.
  • Each year in the past 5 years 1JNJ has been profitable.
  • In the past 5 years 1JNJ always reported a positive cash flow from operatings.
1JNJ.MI Yearly Net Income VS EBIT VS OCF VS FCF1JNJ.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 13.46%, 1JNJ belongs to the top of the industry, outperforming 88.24% of the companies in the same industry.
  • The Return On Equity of 1JNJ (32.87%) is better than 82.35% of its industry peers.
  • The Return On Invested Capital of 1JNJ (15.05%) is better than 76.47% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for 1JNJ is in line with the industry average of 14.21%.
Industry RankSector Rank
ROA 13.46%
ROE 32.87%
ROIC 15.05%
ROA(3y)14.08%
ROA(5y)12.66%
ROE(3y)34.55%
ROE(5y)31.04%
ROIC(3y)15.58%
ROIC(5y)14.64%
1JNJ.MI Yearly ROA, ROE, ROIC1JNJ.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

1.3 Margins

  • The Profit Margin of 1JNJ (28.46%) is better than 92.16% of its industry peers.
  • 1JNJ's Profit Margin has improved in the last couple of years.
  • 1JNJ has a Operating Margin of 28.55%. This is in the better half of the industry: 1JNJ outperforms 76.47% of its industry peers.
  • In the last couple of years the Operating Margin of 1JNJ has grown nicely.
  • 1JNJ has a Gross Margin of 67.98%. This is comparable to the rest of the industry: 1JNJ outperforms 45.10% of its industry peers.
  • In the last couple of years the Gross Margin of 1JNJ has remained more or less at the same level.
Industry RankSector Rank
OM 28.55%
PM (TTM) 28.46%
GM 67.98%
OM growth 3Y-0.34%
OM growth 5Y3.01%
PM growth 3Y8.26%
PM growth 5Y9.82%
GM growth 3Y-0.62%
GM growth 5Y0.68%
1JNJ.MI Yearly Profit, Operating, Gross Margins1JNJ.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. 1JNJ.MI Health Analysis

2.1 Basic Checks

  • 1JNJ has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, 1JNJ has about the same amount of shares outstanding.
  • Compared to 5 years ago, 1JNJ has less shares outstanding
  • The debt/assets ratio for 1JNJ is higher compared to a year ago.
1JNJ.MI Yearly Shares Outstanding1JNJ.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B
1JNJ.MI Yearly Total Debt VS Total Assets1JNJ.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B

2.2 Solvency

  • An Altman-Z score of 5.01 indicates that 1JNJ is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of 1JNJ (5.01) is better than 74.51% of its industry peers.
  • The Debt to FCF ratio of 1JNJ is 2.43, which is a good value as it means it would take 1JNJ, 2.43 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of 1JNJ (2.43) is better than 72.55% of its industry peers.
  • A Debt/Equity ratio of 0.56 indicates that 1JNJ is somewhat dependend on debt financing.
  • The Debt to Equity ratio of 1JNJ (0.56) is comparable to the rest of the industry.
  • Even though the debt/equity ratio score it not favorable for 1JNJ, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 2.43
Altman-Z 5.01
ROIC/WACC1.54
WACC9.74%
1JNJ.MI Yearly LT Debt VS Equity VS FCF1JNJ.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B

2.3 Liquidity

  • 1JNJ has a Current Ratio of 1.03. This is a normal value and indicates that 1JNJ is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of 1JNJ (1.03) is worse than 66.67% of its industry peers.
  • A Quick Ratio of 0.77 indicates that 1JNJ may have some problems paying its short term obligations.
  • The Quick ratio of 1JNJ (0.77) is worse than 72.55% of its industry peers.
Industry RankSector Rank
Current Ratio 1.03
Quick Ratio 0.77
1JNJ.MI Yearly Current Assets VS Current Liabilites1JNJ.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. 1JNJ.MI Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 6.77% over the past year.
  • The Earnings Per Share has been growing slightly by 6.11% on average over the past years.
  • The Revenue has been growing slightly by 7.87% in the past year.
  • 1JNJ shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.67% yearly.
EPS 1Y (TTM)6.77%
EPS 3Y2.06%
EPS 5Y6.11%
EPS Q2Q%-2.53%
Revenue 1Y (TTM)7.87%
Revenue growth 3Y5.6%
Revenue growth 5Y2.67%
Sales Q2Q%9.91%

3.2 Future

  • 1JNJ is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.75% yearly.
  • The Revenue is expected to grow by 6.80% on average over the next years.
EPS Next Y7.91%
EPS Next 2Y8.38%
EPS Next 3Y8.73%
EPS Next 5Y9.75%
Revenue Next Year7.43%
Revenue Next 2Y6.86%
Revenue Next 3Y6.73%
Revenue Next 5Y6.8%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
1JNJ.MI Yearly Revenue VS Estimates1JNJ.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B 80B 100B
1JNJ.MI Yearly EPS VS Estimates1JNJ.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

2

4. 1JNJ.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 21.19, 1JNJ is valued on the expensive side.
  • The rest of the industry has a similar Price/Earnings ratio as 1JNJ.
  • The average S&P500 Price/Earnings ratio is at 26.64. 1JNJ is valued slightly cheaper when compared to this.
  • Based on the Price/Forward Earnings ratio of 17.92, the valuation of 1JNJ can be described as rather expensive.
  • The rest of the industry has a similar Price/Forward Earnings ratio as 1JNJ.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 21.36, 1JNJ is valued at the same level.
Industry RankSector Rank
PE 21.19
Fwd PE 17.92
1JNJ.MI Price Earnings VS Forward Price Earnings1JNJ.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 1JNJ's Enterprise Value to EBITDA ratio is in line with the industry average.
  • 60.78% of the companies in the same industry are cheaper than 1JNJ, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 27.8
EV/EBITDA 16.84
1JNJ.MI Per share data1JNJ.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1JNJ does not grow enough to justify the current Price/Earnings ratio.
  • The decent profitability rating of 1JNJ may justify a higher PE ratio.
PEG (NY)2.68
PEG (5Y)3.47
EPS Next 2Y8.38%
EPS Next 3Y8.73%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. 1JNJ.MI Dividend Analysis

5.1 Amount

  • 1JNJ has a Yearly Dividend Yield of 2.32%. Purely for dividend investing, there may be better candidates out there.
  • 1JNJ's Dividend Yield is a higher than the industry average which is at 1.96.
  • Compared to an average S&P500 Dividend Yield of 1.82, 1JNJ pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.32%

5.2 History

  • The dividend of 1JNJ is nicely growing with an annual growth rate of 7.68%!
Dividend Growth(5Y)7.68%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 1JNJ pays out 46.19% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • The dividend of 1JNJ is growing, but earnings are growing more, so the dividend growth is sustainable.
DP46.19%
EPS Next 2Y8.38%
EPS Next 3Y8.73%
1JNJ.MI Yearly Income VS Free CF VS Dividend1JNJ.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B
1JNJ.MI Dividend Payout.1JNJ.MI Dividend Payout, showing the Payout Ratio.1JNJ.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

1JNJ.MI Fundamentals: All Metrics, Ratios and Statistics

JOHNSON & JOHNSON

BIT:1JNJ (4/29/2026, 7:00:00 PM)

194.14

-7.56 (-3.75%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Industry Strength67.7
Industry Growth15.53
Earnings (Last)04-14
Earnings (Next)07-14
Inst Owners75.61%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap467.61B
Revenue(TTM)96.36B
Net Income(TTM)26.80B
Analysts76.25
Price Target209.41 (7.87%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.32%
Yearly Dividend4.39
Dividend Growth(5Y)7.68%
DP46.19%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.21%
Min EPS beat(2)-0.13%
Max EPS beat(2)0.55%
EPS beat(4)3
Avg EPS beat(4)2.17%
Min EPS beat(4)-0.13%
Max EPS beat(4)5.96%
EPS beat(8)7
Avg EPS beat(8)2.84%
EPS beat(12)10
Avg EPS beat(12)3.23%
EPS beat(16)14
Avg EPS beat(16)3.09%
Revenue beat(2)2
Avg Revenue beat(2)0.35%
Min Revenue beat(2)0.03%
Max Revenue beat(2)0.67%
Revenue beat(4)4
Avg Revenue beat(4)1.04%
Min Revenue beat(4)0.03%
Max Revenue beat(4)2.92%
Revenue beat(8)5
Avg Revenue beat(8)0.32%
Revenue beat(12)8
Avg Revenue beat(12)-0.5%
Revenue beat(16)8
Avg Revenue beat(16)-4.44%
PT rev (1m)6.24%
PT rev (3m)15.18%
EPS NQ rev (1m)-0.22%
EPS NQ rev (3m)-2.64%
EPS NY rev (1m)0.06%
EPS NY rev (3m)0.82%
Revenue NQ rev (1m)0.04%
Revenue NQ rev (3m)1.27%
Revenue NY rev (1m)0.22%
Revenue NY rev (3m)1.83%
Valuation
Industry RankSector Rank
PE 21.19
Fwd PE 17.92
P/S 5.81
P/FCF 27.8
P/OCF 22.33
P/B 6.72
P/tB N/A
EV/EBITDA 16.84
EPS(TTM)9.16
EY4.72%
EPS(NY)10.83
Fwd EY5.58%
FCF(TTM)6.98
FCFY3.6%
OCF(TTM)8.7
OCFY4.48%
SpS33.39
BVpS28.91
TBVpS-6.25
PEG (NY)2.68
PEG (5Y)3.47
Graham Number77.1856 (-60.24%)
Profitability
Industry RankSector Rank
ROA 13.46%
ROE 32.87%
ROCE 18.53%
ROIC 15.05%
ROICexc 17.35%
ROICexgc 70.6%
OM 28.55%
PM (TTM) 28.46%
GM 67.98%
FCFM 20.91%
ROA(3y)14.08%
ROA(5y)12.66%
ROE(3y)34.55%
ROE(5y)31.04%
ROIC(3y)15.58%
ROIC(5y)14.64%
ROICexc(3y)18.74%
ROICexc(5y)17.83%
ROICexgc(3y)70.93%
ROICexgc(5y)71.82%
ROCE(3y)18.94%
ROCE(5y)17.92%
ROICexgc growth 3Y-2.46%
ROICexgc growth 5Y-5.65%
ROICexc growth 3Y1.88%
ROICexc growth 5Y1.69%
OM growth 3Y-0.34%
OM growth 5Y3.01%
PM growth 3Y8.26%
PM growth 5Y9.82%
GM growth 3Y-0.62%
GM growth 5Y0.68%
F-Score4
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 2.43
Debt/EBITDA 1.34
Cap/Depr 64.4%
Cap/Sales 5.13%
Interest Coverage 7
Cash Conversion 71.32%
Profit Quality 73.49%
Current Ratio 1.03
Quick Ratio 0.77
Altman-Z 5.01
F-Score4
WACC9.74%
ROIC/WACC1.54
Cap/Depr(3y)61.79%
Cap/Depr(5y)58.46%
Cap/Sales(3y)5.15%
Cap/Sales(5y)5.02%
Profit Quality(3y)88.82%
Profit Quality(5y)91.38%
High Growth Momentum
Growth
EPS 1Y (TTM)6.77%
EPS 3Y2.06%
EPS 5Y6.11%
EPS Q2Q%-2.53%
EPS Next Y7.91%
EPS Next 2Y8.38%
EPS Next 3Y8.73%
EPS Next 5Y9.75%
Revenue 1Y (TTM)7.87%
Revenue growth 3Y5.6%
Revenue growth 5Y2.67%
Sales Q2Q%9.91%
Revenue Next Year7.43%
Revenue Next 2Y6.86%
Revenue Next 3Y6.73%
Revenue Next 5Y6.8%
EBIT growth 1Y15.95%
EBIT growth 3Y5.24%
EBIT growth 5Y5.76%
EBIT Next Year23.27%
EBIT Next 3Y11.78%
EBIT Next 5Y9.67%
FCF growth 1Y-0.73%
FCF growth 3Y4.65%
FCF growth 5Y-0.49%
OCF growth 1Y1.09%
OCF growth 3Y4.99%
OCF growth 5Y0.83%

JOHNSON & JOHNSON / 1JNJ.MI Fundamental Analysis FAQ

What is the fundamental rating for 1JNJ stock?

ChartMill assigns a fundamental rating of 5 / 10 to 1JNJ.MI.


What is the valuation status for 1JNJ stock?

ChartMill assigns a valuation rating of 2 / 10 to JOHNSON & JOHNSON (1JNJ.MI). This can be considered as Overvalued.


How profitable is JOHNSON & JOHNSON (1JNJ.MI) stock?

JOHNSON & JOHNSON (1JNJ.MI) has a profitability rating of 7 / 10.


What is the expected EPS growth for JOHNSON & JOHNSON (1JNJ.MI) stock?

The Earnings per Share (EPS) of JOHNSON & JOHNSON (1JNJ.MI) is expected to grow by 7.91% in the next year.


How sustainable is the dividend of JOHNSON & JOHNSON (1JNJ.MI) stock?

The dividend rating of JOHNSON & JOHNSON (1JNJ.MI) is 6 / 10 and the dividend payout ratio is 46.19%.